Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen

Neoplasma

Volumn 43, Issue 1, 1996, Pages 27-29

  Tsai, Shih Chuan ^a   Kao, Chia Hung ^a   Wang, Shyh Jem ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

CYFRA 21 1; SCC; squamous cell carcinoma of the cervix

Indexed keywords

CYTOKERATIN; CYTOKERATIN 19 FRAGMENT; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; UTERINE CERVIX CARCINOMA;

EID: 0029927546     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BODENMULLER, H., BANAUCH, D., OFENLOCH, B., JAWOREK, D., DESSAUER, A.: Technical evaluation of a new automated tumor marker assay: The Enzyme-Test CYFRA 21-1. In: Tumor Associated Antigens, Oncogenes, Receptors, Cytokines in Tumor Diagnosis and Therapy at the Beginning of the 90th. Ed.: Klapdor, R. Zuckschwerdt Verlag 1992, 137-138.
2. BODENMULLER, H., OFENLOCH HAHNLE, B., LANE, E.B., DESSAUER, A., BOTTGER, V., DONIE, F.: Lung cancer-associated keratin 19 fragments: Development and biochemical characterisation of the new serum assay Enzymun-Test CYFRA 21-1. Int. J. Biol. Markers, 9, 1994, 75-81.
3. BOLLI, J.A., DOERING, D.L., BOSSCHER, J.R., DAY, T.G. JR., RAO, C.V., OWENS, K., KELLY, B., GOLDSMITH, J.: Squamous cell carcinoma antigen: Clinical utility in squamous cell carcinoma of uterine cervix. Gynecol. Oncol., 55, 1994, 169-173.
4. BROERS, J.L., ROT, M.K., OOSTENDROP, T., HUYSMANS, A., WAGENAAR, S.S., WIERSMA-VAN-TILBURG, A.J. et al.: Immunohistochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal and neuroendocrine antigens. Cancer Res., 47, 1987, 3225-3234.
5. BROERS, J.L., RAMAEKERS, F.C., ROT, M.K., OOSTENDROP, T., HUYSMANS, A., UYN MUIJEN, G.N. et al.: Cytokeratins in different types of human lung as monitored by chain-specific monoclonal antibodies. Cancer Res., 48, 1988, 3221-3229.
6. CHEAH, P.L., YAP, S.F., LOOI, L.M., SIVANESARATNAM, V.: Squamous cell carcinoma related antigen in uterine cervical carcinoma. Malays. J. Pathol, 13, 1991, 37-41.
7. FERDEGHINI, M., GADDUCCI, A., ANNICCHIARICO, C., PRONTERA, C., MALAGNINO, G., CASTELLANI, C., FACCHINI, V., BIANCHI, R.: Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix. Anticancer Res., 13, 1993, 1841-1844.
8. FERDEGHINI, M., GADDUCCI, A., PRONTERA, C., CASTELLANI, C., ANNICCHIARICO, C., GAGETTI, O., FACCHINI, V., BIANCHI, R.: Determination of serum levels of different cytokeratins in patients with uterine malignancies. Anticancer Res., 14, 1994, 1393-1397.
9. GIGI-LEITNER, O., GEIGER, B., LEVY, R., CZERNOBILSKY, B.: Cytokeratin expression in squamous metaplasia of the human uterine cervix. Tumour Biol., 15, 1994, 318-325.
10. HABETS, J.M., TANK, B., VUZEVSKI, V.D., BREVE, J., VAN DER KWAST, T., VAN JOOST, T.: Immunoelectron microscopic studies on cytokeratins in human basal cell carcinoma. Anticancer Res., 9, 1989, 65-70.
11. HOEFLIGER, M., MORANT, R., RIESEN, W., BAUMGARTNER, G., ENGLER, H.: CYFRA 21-1: Initial experiences in bronchus carcinoma and other tumors. Schweiz. Med. Wochenschr., 124, 1994, 1966-1970.
12. KARSTEN, U., PAPSDORF, G., ROLOFF, G., STOLLE, P., ABEL, H., WALTHER, I., WEISS, H.: Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion. Eur. J. Cancer. Clin. Oncol., 21, 1985, 733-740.
13. KASPER, M., STOSIEK, P., TYPLT, H., KARSTEN, U.: Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues. Eur. J. Cancer. Clin. Oncol., 23, 1987, 137-147.
14. KATO, H., TORIGOE, T.: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer, 40, 1977, 1621-1628.
15. KATO, H., TIMPANI, K., MAGAYA, T., NAGAI, M., NOGUCHI, H., SUCHIRO, Y., TORIGOE, T.: Clinical value of SCC antigen, a sub fraction of tumor antigen TA-4, in the management of cervical cancer. Jpn. J. Cancer. Clin., Suppl. 6, 31, 1985, 594-599.
16. KOGA, H., EGUCHI, K_, SHINKAI, T., TAMURA, T., OHE, Y., OSHITA, E, SAIJO, N., KONDO, H., OKI, K., OKURA, H.: Preliminary evaluation of the new tumor marker, CYFRA 21-1, in lung cancer patients. Jpn. J. Clin. Oncol., 24, 1994, 263-268.
17. MOLINA, R., AGUSTI, C., FILELLA, X., JO, J., JOSEPH, J., GIMENEZ, N., BALLESTA, A.M.: Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases. Differentiation, 31, 1986, 191-205.
18. NIKLINSKI, J., FURMAN, M., CHYCZEWSKA, E., CHYCZEWSKI, L., ROGOWSKI, F., JAROSZEWICZ, E., LAUDANSKI, J.: Evaluation of CYFRA 21-1 as a new marker for non-small cell lung cancer. Eur. J. Cancer. Prev., 3, 1994, 227-230.
19. SENEKJIAN, E.K., YOUNG, J.M., WEISER, P.A., SPENCER, C. E., MAGIC, S.E., HERBST, A.L. : An evaluation of squamous cell carcinoma antigen in patients with cervical squamous carcinoma. Am. J. Obstet. Gynecol., 157, 1987, 433-439.